Biomarkers Market Size, Share, trends and Forecast|Report 2026
The Biomarkers market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, October 16, 2019 ) Market Overview:
Biomarkers are used for the diagnosis health status of an individual. In medical terms, a measurable biomarker is a chemical component which reflects the presence as well as the severity of the disease. Biomarkers have an important function in the early detection of various diseases.
Market Dynamics:
The Biomarkers market growth is driven by therising ageing population and increasing incidence of chronic diseases such as cancer, cardiovascular diseases and neurological disorders. In addition, increasing regulatory approval for biomarkers, rising demand in drug discovery, growing emphasis on personalized medicine and companion diagnostics are some of the other factors driving the growth of the biomarkers market globally.
However, high investment costs and problems associated such as sample storage & collection is hampering the growth of the biomarker market.
Market Segmentation:
On the basis of product type, the Biomarkers Market is segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. Among these, Efficacy biomarker segment accounted for the largest market share and growing at a significant CAGR.
Geographical Analysis:
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
North America is dominating the Biomarkers market in 2018 and estimated to hold largest market size over the forecast period (2019-2026). The U.S. biomarkers market will lead biomarkers market due to favorable healthcare infrastructure as well as availability of technologically advanced products. Rising investment in drug discovery, diagnostics along with rising cancer patient pool will further stimulate the biomarkers market growth.
Competitive Analysis:
Some of the major players include Bio-Rad Laboratories Inc., Merck Millipore, Qiagen N.V., Siemens Healthcare, Abbott Laboratories, Affymetrix Inc., (Thermo Fisher Scientific), Signosis, Inc., EKF Diagnostics Holdings, Inc., Biosims Technologies Sas, and Cisbio Bioassays.
View full report: https://www.datamintelligence.com/research-report/biomarkers-market
Download free sample: https://www.datamintelligence.com/download-sample/biomarkers-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: pr@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Biomarkers are used for the diagnosis health status of an individual. In medical terms, a measurable biomarker is a chemical component which reflects the presence as well as the severity of the disease. Biomarkers have an important function in the early detection of various diseases.
Market Dynamics:
The Biomarkers market growth is driven by therising ageing population and increasing incidence of chronic diseases such as cancer, cardiovascular diseases and neurological disorders. In addition, increasing regulatory approval for biomarkers, rising demand in drug discovery, growing emphasis on personalized medicine and companion diagnostics are some of the other factors driving the growth of the biomarkers market globally.
However, high investment costs and problems associated such as sample storage & collection is hampering the growth of the biomarker market.
Market Segmentation:
On the basis of product type, the Biomarkers Market is segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. Among these, Efficacy biomarker segment accounted for the largest market share and growing at a significant CAGR.
Geographical Analysis:
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
North America is dominating the Biomarkers market in 2018 and estimated to hold largest market size over the forecast period (2019-2026). The U.S. biomarkers market will lead biomarkers market due to favorable healthcare infrastructure as well as availability of technologically advanced products. Rising investment in drug discovery, diagnostics along with rising cancer patient pool will further stimulate the biomarkers market growth.
Competitive Analysis:
Some of the major players include Bio-Rad Laboratories Inc., Merck Millipore, Qiagen N.V., Siemens Healthcare, Abbott Laboratories, Affymetrix Inc., (Thermo Fisher Scientific), Signosis, Inc., EKF Diagnostics Holdings, Inc., Biosims Technologies Sas, and Cisbio Bioassays.
View full report: https://www.datamintelligence.com/research-report/biomarkers-market
Download free sample: https://www.datamintelligence.com/download-sample/biomarkers-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: pr@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results